Temperature and sleep changes
A hot flash is a sudden wave of heat through the chest and face, often followed by sweating and then a chill. At night the same event wakes you, and the fatigue that follows is what sends women to a clinic.
Fezolinetant, approved by the FDA in May 2023, works by blocking a neurokinin 3 receptor in the part of the brain that regulates temperature. That mechanism matters for understanding the symptom: hot flashes are a thermoregulatory misfire.
Mood and cognitive changes
Low mood and a slippery memory for names and words are common in this window, and they're real. SWAN found women were two to four times more likely to have a major depressive episode during perimenopause or early postmenopause than before it, independent of hot flashes and hormone levels.
Untreated insomnia and thyroid disease produce the same fog and the same short fuse. When menopause symptoms and one of these overlap, treating only the hormonal side leaves half the problem in place.
Sexual and urinary changes
Thinner, less elastic vaginal tissue produces dryness and pain with sex. Desire drops because of the pain and on its own. On the urinary side, urgency, frequency, and repeat infections belong to the same syndrome, which is why they're worth raising together.
There's a reason to name them out loud. Vaginal estrogen cut recurrent urinary tract infections in a meta-analysis of five trials in 1,936 patients, with a relative risk of 0.42. Symptoms nobody mentions don't get that treatment.
Bone and metabolic changes
Bone loss has no symptoms until something breaks. Neither does a rising cholesterol panel. That silence is the argument for screening.
Body composition shifts in a way the scale hides. In SWAN's imaging study of 1,246 women, the rate of fat gain doubled to 1.7% per year at the start of the transition while lean mass began to decline, and total weight climbed on the same straight line it had followed before. Muscle loss and abdominal fat redistribution belong in the conversation. Attributing every pound to estrogen does not.
What needs evaluation
Most of what happens in this transition is bothersome. Some of it isn't. Sorting the two is the part worth getting right.
-
Emergency care: chest pain or pressure, or thoughts of suicide.
-
Prompt evaluation, within days: any bleeding after 12 period-free months, or new pelvic pain.
-
Routine evaluation: persistent urinary symptoms and painful sex.
Postmenopausal bleeding earns its own line. In a meta-analysis of 129 studies covering 40,790 women, 9% of those with postmenopausal bleeding were diagnosed with endometrial cancer, and 90% of endometrial cancers had produced bleeding first. The odds favor a benign cause, which is exactly why the workup is quick and worth doing.
How diagnosis works
Diagnosis is clinical. Age and menstrual history carry it. NICE guidance is blunt on the lab question: don't use follicle-stimulating hormone or estradiol to diagnose perimenopause in people 45 or older, because levels swing week to week and the result won't change management.
Testing earns its place when the story doesn't fit. Repeated FSH levels help if you're under 45 with menopause symptoms, or under 40 with suspected primary ovarian insufficiency. Pregnancy testing settles a missed period while cycles continue. Thyroid function and a blood count rule out the conditions that imitate menopause symptoms. Pelvic ultrasound or endometrial biopsy follows abnormal bleeding, and bone density testing by DXA is recommended by the USPSTF for women 65 or older and for younger postmenopausal women at increased fracture risk.